The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
Open accessPublished version of a preprint
Abstract
BACKGROUND: A person's rate of aging has important implications for his/her risk of death and disease; thus, quantifying aging using observable characteristics has important applications for clinical, basic, and observational research. Based on routine clinical chemistry biomarkers, we previously developed a novel aging measure, Phenotypic Age, representing the expected age within the population that corresponds to a person's estimated mortality risk. The aim of this study was to assess its applicability for differentiating risk for a variety of health outcomes within diverse subpopulations that include healthy and unhealthy groups, distinct age groups, and persons with various race/ethnic, socioeconomic, and health behavior characteristics. METHODS AND FINDINGS: Phenotypic Age was calculated based on a linear combination of chronological age and 9 multi-system clinical chemistry biomarkers in accordance with our previously established method. We also estimated Phenotypic Age Acceleration (PhenoAgeAccel), which represents Phenotypic Age after accounting for chronological age (i.e., whether a person appears older [positive value] or younger [negative value] than expected, physiologically). All analyses were conducted using NHANES IV (1999-2010, an independent sample from that originally used to develop the measure). Our analytic sample consisted of 11,432 adults aged 20-84 years and 185 oldest-old adults top-coded at age 85 years. We observed a total of 1,012 deaths, ascertained over 12.6 years of follow-up (based on National Death Index data through December 31, 2011). Proportional hazard models and receiver operating characteristic curves were used to evaluate all-cause and cause-specific mortality predictions. Overall, participants with more diseases had older Phenotypic Age. For instance, among young adults, those with 1 disease were 0.2 years older phenotypically than disease-free persons, and those with 2 or 3 diseases were about 0.6 years older phenotypically. After adjusting for chronological age and sex, Phenotypic Age was significantly associated with all-cause mortality and cause-specific mortality (with the exception of cerebrovascular disease mortality). Results for all-cause mortality were robust to stratifications by age, race/ethnicity, education, disease count, and health behaviors. Further, Phenotypic Age was associated with mortality among seemingly healthy participants-defined as those who reported being disease-free and who had normal BMI-as well as among oldest-old adults, even after adjustment for disease prevalence. The main limitation of this study was the lack of longitudinal data on Phenotypic Age and disease incidence. CONCLUSIONS: In a nationally representative US adult population, Phenotypic Age was associated with mortality even after adjusting for chronological age. Overall, this association was robust across different stratifications, particularly by age, disease count, health behaviors, and cause of death. We also observed a strong association between Phenotypic Age and the disease count an individual had. These findings suggest that this new aging measure may serve as a useful tool to facilitate identification of at-risk individuals and evaluation of the efficacy of interventions, and may also facilitate investigation into potential biological mechanisms of aging. Nevertheless, further evaluation in other cohorts is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290 · cited 1×
“Cause-specific mortality risk as a function of Phenotypic Age was assessed via Fine and Gray’s competing risk models [26].”
MethodDNA methylation age of human tissues and cell types
Horvath, S. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r115 · Cited by 7,075
Self-citationAn epigenetic biomarker of aging for lifespan and healthspan
Levine, M. E., Lu, A. T., Quach, A., Chen, B. H., Assimes, T. L., Bandinelli, S., Hou, L., Baccarelli, A. A., Stewart, J. D., Li, Y., et al. (2018) · Aging · doi:10.18632/aging.101414 · Cited by 3,675 · cited 3×
“We calculated Phenotypic Age in accordance with the method described previously [12].”
MethodInfluentialSelf-citationFrailty in relation to the accumulation of deficits
Rockwood, K., & Mitnitski, A. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.7.722 · Cited by 3,076 · cited 1×
“Many of the measures of aging, such as those based on deficit accumulation [14,27], include measures of morbidity in their construction, and thus it is impossible to disentangle aging and disease, or determine the usefulness of such measures in healthy populations.”
BackgroundAccumulation of Deficits as a Proxy Measure of Aging
Mitnitski, A. B., Mogilner, A. J., & Rockwood, K. (2001) · The Scientific World JOURNAL · doi:10.1100/tsw.2001.58 · Cited by 2,893 · cited 1×
“Many of the measures of aging, such as those based on deficit accumulation [14,27], include measures of morbidity in their construction, and thus it is impossible to disentangle aging and disease, or determine the usefulness of such measures in healthy populations.”
BackgroundGeroscience: Linking Aging to Chronic Disease
Kennedy, B. K., Berger, S. L., Brunet, A., Campisi, J., Cuervo, A. M., Epel, E. S., Franceschi, C., Lithgow, G. J., Morimoto, R. I., Pessin, J. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.039 · Cited by 2,764
National Health and Nutrition Examination Survey
(2010) · Handbook of Disease Burdens and Quality of Life Measures · doi:10.1007/978-0-387-78665-0_6177 · Cited by 2,087
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.2307/2670170 · Cited by 1,375
National Health and Nutrition Examination Survey
(2008) · Encyclopedia of Epidemiology · doi:10.4135/9781412953948.n305 · Cited by 1,342
DNA methylation age of blood predicts all-cause mortality in later life
Marioni, R. E., Shah, S., McRae, A. F., Chen, B. H., Colicino, E., Harris, S. E., Gibson, J., Henders, A. K., Redmond, P., Cox, S. R., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0584-6 · Cited by 1,261
Self-citation
Cited by
Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality
Tian, Y. E., Cropley, V., Maier, A. B., Lautenschlager, N. T., Breakspear, M., & Zalesky, A. (2023) · Nature Medicine · doi:10.1038/s41591-023-02296-6 · Cited by 618
Kwon, D., & Belsky, D. W. (2021) · GeroScience · doi:10.1007/s11357-021-00480-5 · Cited by 410
“The BioAge R package is an easy to install tool that can implement the Klemera-Doubal [27], PhenoAge [34], and homeostatic dysregulation [28] methods following the approach we have used in previous work [24, 31, 43, 45].”
MethodPersonal aging markers and ageotypes revealed by deep longitudinal profiling
Ahadi, S., Zhou, W., Schüssler-Fiorenza Rose, S. M., Sailani, M. R., Contrepois, K., Avina, M., Ashland, M., Brunet, A., & Snyder, M. (2020) · Nature Medicine · doi:10.1038/s41591-019-0719-5 · Cited by 408
Melzer, D., Pilling, L. C., & Ferrucci, L. (2020) · Nature Reviews Genetics · doi:10.1038/s41576-019-0183-6 · Cited by 363
Self-citationValidation of biomarkers of aging
Moqri, M., Herzog, C., Poganik, J. R., Ying, K., Justice, J. N., Belsky, D. W., Higgins-Chen, A. T., Chen, B. H., Cohen, A. A., Fuellen, G., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02784-9 · Cited by 361
“While many composite biomarkers of aging have shown some evidence of comparable predictive accuracy across genetic ancestry populations 25,71,72 , establishing diverse cohorts with non-European ancestries to validate new composite biomarkers of aging remains a priority.”
Self-citation
Metadata
- Authors
- Liu, Z., Kuo, P.-L., Horvath, S., Crimmins, E., Ferrucci, L., & Levine, M.
- Affiliations
- Yale University (US)
- National Institutes of Health (US)
- University of California, Los Angeles (US)
- University of Southern California (US)
- Corresponding author
- Liu, Zuyun
- Kuo, Pei-Lun
- Horvath, Steve
- Crimmins, Eileen
- Ferrucci, Luigi
- Levine, Morgan
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-12-31
- Volume
- 15
- Issue
- 12
- Pages
- e1002718
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC6312200
- OpenAlex
- W2908077673
- Cited by
- 754
- References
- 35
- Citations by year
- 2026: 178 · 2025: 206 · 2024: 161 · 2023: 75 · 2022: 48 · 2021: 43 · 2020: 23 · 2019: 18 · 2018: 2
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-02-25)
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS Medicine (publishedVersion, public-domain)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, public-domain)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute on Aging (4R00AG052604-02)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Social Sciences › Psychology › Developmental and Educational Psychology › Aging and Gerontology Research
- Keywords
- phenotypic age, phenotypic age acceleration, biological aging, mortality prediction, morbidity, all-cause mortality, cause-specific mortality, oldest old, healthy young adults, racial and ethnic differences, socioeconomic status, health behavior, disease burden, mortality risk stratification
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Female, Follow-Up Studies, Humans, Male, Middle Aged, Morbidity, Mortality, Nutrition Surveys, Population Surveillance, Risk Factors, Cohort Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study. https://app.cochat.ai/papers/10.1371/journal.pmed.1002718
- The paper
- Liu, Z., Kuo, P.-L., Horvath, S., Crimmins, E., Ferrucci, L., & Levine, M. (2018). A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002718
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.